The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow

Description

No / Since the development of the first cytotoxic agents, synthetic organic chemistry has advanced
enormously. The synthetic and medicinal chemists of today are at the centre of drug development and
are involved in most, if not all, processes of drug discovery. Recent decreases in government funding and
reformed educational policies could, however, seriously impact on drug discovery initiatives worldwide.
Not only could these changes result in fewer scientific breakthroughs, but they could also negatively
affect the training of our next generation of medicinal chemists.

Links & Downloads

1. Pors K, Goldberg FW, Leamon CP et al (2009) The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow. Drug Discovery Today. 14 (21/22): 1045-50.
2. http://hdl.handle.net/10454/8821
3. https://doi.org/10.1016/j.drudis.2009.07.004

Tags

Medicinal chemistry

Chemical biology

Diversity-oriented synthesis

EPSRC

Government funding

NCI

Cancer drug discovery

Additional Fields

Identifer	oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/8821
Date	11 1900
Creators	Pors, Klaus, Goldberg, F.W., Leamon, C.P., Rigby, A.C., Snyder, S.A., Falconer, Robert A.
Source Sets	Bradford Scholars
Language	English
Detected Language	English
Type	Article, No full-text in the repository